Known for being the seventh largest pharmaceutical venture based in revenue and market capitalization, Merck is known for producing some of the world’s first vaccines and antibacterials. They are also credited for the discovery and formulation of Thiazide Anti-hypertensives, First Statin, Mectizan, Fosamax and Vioxx. Through the research and development efforts of the company and through their collaborative partnership with other blossoming pharmaceutical companies, more and more drugs have been granted approval for commercialization. Some of the newly approved drugs include Januvia, Zetia, Remicade, Gardasil, Keytruda and Insentress.
As a company that leads the way to a healthier future, the business continues to uphold the highest degree of ethics and integrity. As they touch lives, they also concern themselves about how they are able to paint the future by ensuring their compliance with any laws and regulations around the world. Through their code of conduct and their guidelines of ethics, they continue to operate with the highest ethical business practices and behavior.
As one of the leading pharmaceutical businesses, the company has an aggressive stance in acquiring similar ventures. In fact, in December 2014 alone, while the company is still in talks about acquiring Cubist Pharmaceuticals, they have already acquired OncoEthix, a Swiss biotechnology company. Through these acquisitions, the business is able to broaden their product offerings and enhance the development of novelty therapeutics.